AI-generated summary
The authors studied primary skin fibroblasts from people with and without diabetes and tested whether low-level red laser light (632.8 nm) changed their behavior and secretion of 60 growth factors and cytokines. They report that the laser compensated for several impairments in diabetic fibroblasts, including viability, proliferation and migration, and restored seven of twenty affected signaling molecules. The findings come from cell culture experiments.
- Who or what was studied
- Primary human dermal fibroblasts from normal donors and from donors with diabetes
- Limits stated in the abstract
- The abstract describes an in vitro cell study, so the findings may not translate directly to patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 0.5 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Wound healing, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.